Congenica Ltd
| Private Company limited by shares (Ltd) | |
| ISIN | 🆔 |
| Industry | Biotechnology Life Sciences |
| Founded 📆 | 2012 |
| Founder 👔 | |
| Headquarters 🏙️ | , |
Area served 🗺️ | |
Key people | Dr Thomas Weaver (CEO); Dr Nick Lench; Dr Richard Durbin; Dr Matthew Hurles; Dr Philip Beales; Shikha O'Brien |
| Members | |
Number of employees | |
| 🌐 Website | www |
| 📇 Address | |
| 📞 telephone | |
Congenica Ltd is a biotechnology company located in Cambridge, UK at the Wellcome Genome Campus and has developed genome interpretation software.
History[edit]
Congenica was first incorporated in 2012.[1] Congenica develops and markets products and services for the interpretation of human genomic data with a focus on rare disease and was built upon technologies developed by the Wellcome Trust Sanger Institute.
Congenica was chosen by Genomics England to provide clinical interpretation services for the 100,000 Genomes Project along with three other companies in 2015[2][3][4]. The company was selected by Genomics England in its Small Business Research Initiative Phase Two assessment on Enabling Technologies for Genomics Sequence Data Analysis and Interpretation[5].
Technology[edit]
Sapientia Congenica’s product Sapientia assists in the interpretation of genetic mutations found in human genomes to facilitate a clinical diagnosis.
Practical Applications Application of the Sapientia technology includes genetic clinical laboratories and medical hospitals, such as Central Manchester University Hospitals NHS Foundation Trust (CMFT) Manchester Centre for Genomic Medicine (MCGM)[6][7] and the PAGE research project with Birmingham Women’s Foundation Trust and the University College Hospital Foundation Trust[8].
See also[edit]
External Links[edit]
References[edit]
- ↑ "Healthcare Technology Company Congenica Company Overview". Bloomberg. Retrieved 11 August 2017.
- ↑ "Four Firms Tapped to Provide Clinical Interpretation Services for UK 100K Genomes Effort". GenomeWeb. Retrieved 3 June 2015.
- ↑ "Genomics England picks partners for UK100K project". Pharmatimes. Retrieved 14 October 2014.
- ↑ "Sapientia Detecting Clinically Relevant Variants In 35% Of First Diagnostic Reports Delivered To UK 100,000 Genomes Project". Congenica. Retrieved 20 October 2016.
- ↑ "Genomics England announces successful companies in Small Business Research Initiative (SBRI) for a share of £8 million". Genomics England. Retrieved 11 March 2015.
- ↑ "Faster, more accurate diagnosis for genetic disease reaches patients". Manchester Centre for Genomic Medicine. Retrieved 8 June 2015.
- ↑ "Congenica Announces First Clinical Customer for Sapientia Platform". GenomeWeb. Retrieved 10 June 2015.
- ↑ "Congenica's Sapientia selected for 'PAGE' prenatal genetic testing project". Congenica. Retrieved 22 June 2016.
 | This technology article about a corporation or company is a stub. You can help EverybodyWiki by expanding it. |
This article "Congenica" is from Wikipedia. The list of its authors can be seen in its historical. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
